Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |